LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.1
71.78 27.76 1351 6893 0.1960 0.6296
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
71.78 27.76 1386 6893 0.2011 0.6348
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
73.48 27.76 1199 6957 0.1723 0.6040
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
73.48 27.76 1258 6957 0.1808 0.6137
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
73.48 27.76 1373 6957 0.1973 0.6315
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
73.48 27.76 1403 6957 0.2016 0.6360
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
75.19 27.76 1174 7015 0.1674 0.5987
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
75.19 27.76 1252 7015 0.1785 0.6116
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
75.19 27.76 1354 7015 0.1930 0.6275
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
75.19 27.76 1396 7015 0.1990 0.6337
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
76.89 27.76 1194 7025 0.1700 0.6019
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
76.89 27.76 1271 7025 0.1809 0.6145
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
76.89 27.76 1357 7025 0.1932 0.6277
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
76.89 27.76 1408 7025 0.2004 0.6353
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
78.60 27.76 1143 7045 0.1622 0.5927
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
78.60 27.76 1250 7045 0.1774 0.6107
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
78.60 27.76 1348 7045 0.1913 0.6260
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
78.60 27.76 1393 7045 0.1977 0.6327
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
80.31 27.76 1146 6976 0.1643 0.5946
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
80.31 27.76 1251 6976 0.1793 0.6122
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
80.31 27.76 1339 6976 0.1919 0.6260
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
80.31 27.76 1407 6976 0.2017 0.6362
MN20160318_Q01
L05
MCF 10A-H2B-mCherry Trametinib
0.1
82.01 27.76 1131 7000 0.1616 0.5915
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
82.01 27.76 1245 7000 0.1779 0.6108
MN20160318_Q01
L03
MCF 10A-H2B-mCherry Trametinib
0.1
82.01 27.76 1274 7000 0.1820 0.6154
MN20160318_Q01
L05